Angiodynamics Stock Market Value
| ANGO Stock | USD 9.75 0.11 1.12% |
| Symbol | AngioDynamics |
AngioDynamics Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.45) | Revenue Per Share | Quarterly Revenue Growth (0.08) | Return On Assets | Return On Equity |
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
AngioDynamics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to AngioDynamics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of AngioDynamics.
| 01/28/2025 |
| 02/27/2025 |
If you would invest 0.00 in AngioDynamics on January 28, 2025 and sell it all today you would earn a total of 0.00 from holding AngioDynamics or generate 0.0% return on investment in AngioDynamics over 30 days. AngioDynamics is related to or competes with AptarGroup, Repro Med, AtriCure, Akoya Biosciences, ICU Medical, Haemonetics, and Merit Medical. AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professio... More
AngioDynamics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure AngioDynamics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess AngioDynamics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.83 | |||
| Information Ratio | 0.1157 | |||
| Maximum Drawdown | 46.09 | |||
| Value At Risk | (3.94) | |||
| Potential Upside | 4.31 |
AngioDynamics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for AngioDynamics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as AngioDynamics' standard deviation. In reality, there are many statistical measures that can use AngioDynamics historical prices to predict the future AngioDynamics' volatility.| Risk Adjusted Performance | 0.0944 | |||
| Jensen Alpha | 0.6714 | |||
| Total Risk Alpha | 0.7426 | |||
| Sortino Ratio | 0.2463 | |||
| Treynor Ratio | (0.24) |
AngioDynamics Backtested Returns
AngioDynamics appears to be slightly risky, given 3 months investment horizon. AngioDynamics secures Sharpe Ratio (or Efficiency) of 0.12, which signifies that the company had a 0.12 % return per unit of standard deviation over the last 3 months. By analyzing AngioDynamics' technical indicators, you can evaluate if the expected return of 0.77% is justified by implied risk. Please makes use of AngioDynamics' risk adjusted performance of 0.0944, and Mean Deviation of 3.02 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, AngioDynamics holds a performance score of 9. The firm shows a Beta (market volatility) of -2.84, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning AngioDynamics are expected to decrease by larger amounts. On the other hand, during market turmoil, AngioDynamics is expected to outperform it. Please check AngioDynamics' jensen alpha, skewness, relative strength index, as well as the relationship between the value at risk and day median price , to make a quick decision on whether AngioDynamics' price patterns will revert.
Auto-correlation | 0.38 |
Below average predictability
AngioDynamics has below average predictability. Overlapping area represents the amount of predictability between AngioDynamics time series from 28th of January 2025 to 12th of February 2025 and 12th of February 2025 to 27th of February 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of AngioDynamics price movement. The serial correlation of 0.38 indicates that just about 38.0% of current AngioDynamics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.38 | |
| Spearman Rank Test | 0.55 | |
| Residual Average | 0.0 | |
| Price Variance | 0.12 |
AngioDynamics lagged returns against current returns
Autocorrelation, which is AngioDynamics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting AngioDynamics' stock expected returns. We can calculate the autocorrelation of AngioDynamics returns to help us make a trade decision. For example, suppose you find that AngioDynamics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
AngioDynamics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If AngioDynamics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if AngioDynamics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in AngioDynamics stock over time.
Current vs Lagged Prices |
| Timeline |
AngioDynamics Lagged Returns
When evaluating AngioDynamics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of AngioDynamics stock have on its future price. AngioDynamics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, AngioDynamics autocorrelation shows the relationship between AngioDynamics stock current value and its past values and can show if there is a momentum factor associated with investing in AngioDynamics.
Regressed Prices |
| Timeline |
When determining whether AngioDynamics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AngioDynamics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Angiodynamics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Angiodynamics Stock:
Check out AngioDynamics Correlation, AngioDynamics Volatility and AngioDynamics Alpha and Beta module to complement your research on AngioDynamics. To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
AngioDynamics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.